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Vancomycin is a glycopeptide antibiotic that is active
against staphylococci, streptococci, and other grampositive bacteria. It is the drug of choice for the treatment
of infection due to methicillin-resistant staphyococci,
Corynebacterium jeikeium, and multiple resistant strains
of Streptococcus pneumoniae. Vancomycin is an
alternative treatment for serious the use of penicilins and
cephalosporins (1-3). The most common adverse effects
of vancomycin are “red man syndrome” and hypotension,
both due to histamine relase (4-6). Other adverse
reactions are drug-associated fever, other hypersensitivity
reactions, otoxicity, nephrotoxicity, Stevens-Johnson-type
reaction, and toxic epidermal necrolysis (6-8).
In this article, we present a case which developed a
lupus erythematosuslike (LE) reaction in the course of
vancomycin treatment. To our knowledge, this
association has been previously suggested in only one
published report (9).
A 57-year-old man was admitted to hospital because
of fever, nausea, vomiting, and exhaustion on April 27,
1996. On physical examination, his temperature was
39°C orally, his pulse rate was 73/min, and respiration
rate was 24/min. His blood pressure was 120/80 mm Hg.
He had bilateral conjunctival hemorrhage and grade 3/6
systolic murmur on cardiac auscultation. The other
physical findings were normal.
Pertinent laboratory studies on admission included a
white blood cell count of 14,800/mm3, with 72%
polymorphonuclear leukocytes, 12% band forms 16%
Iymphocytes. The hematocrit was 39.7%, platelet count
122,000 per cubic millimeter. The prothrombin and
partial-tromboplastin times were normal, and

sedimentation rate was 61 mm/hour. Blood urea
nitrogen, serum creatinine, glucose, bilirubin and other
biochemical parameters were normal. Aspartate amino
trasferase (AST) was 71 mmol/It (normal range 5-35
mmol/It) and alanine amino transferase (ALT) 107
mmol/It (normal range 5-40 mmol/It). Urine analysis
revealed microscopic hematuria. Echocardiography
revealed moderately aortic stenosis, mitral stenosis,
aortic failure, and valvular vegetation. Based on these
cardiac findings, endocarditis was suspected. Six samples
of blood were collected for microbiological diagnosis. The
patient was started on vancomycin hydrochloride (2g/day,
in 4 divided doses) empirically. All blood cultures yield S.
aureus. Echocardiographic findings together with blood
cultures clearly confirmed the diagnosis of staphylococcal
endocarditis. The patient’s clinical course started to
improve three days after initiation of vancomycin therapy.
On vancomycin day 22, he develped fever (38°C) and
a pruritic, erythematous, macular skin rash, distributed in
a generalized fashion over his body, including the palms
and soles. Shortly thereafter, palpebral and conjunctival
edema and hypotension, malaise, arthralgia and myalgia
also developed. Laboratory findings showed an
erythrocyte sedimentation rate of 75mm in the first
hour; the white blood cell count normal; serum AST and
ALT were elevated. The IgE and complement levels were
normal.
Vancomycin was suspected as the etiologic agent of
the patient’s skin and mucosal reaction, and was
discontinued. His other medications were not changed.
The patient was started on sulbactam-ampicillin and
netilmicin therapy according to results of antimicrobial
sensitivity testing.
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Two pieces of punch biopsy from the edge of a dermal
lesion each measuring 6mm in size were obtained and
investigated histopathologically. Microscopic examination
of the biopsy samples revealed epidermal keratosis,
hydropic degeneration in the basal cells, prominent mixed
infiltrate composed primarily of neutrophils and
Iymphocytes around the vessels. Extravasation of red cells
was also noted. These histopathological findings were
similar to those found in drugs related to lupus
erythematosus-like reactions (Figures 1, 2).
Immunofluorescence studies were negative. Rheumatoid
factor, anti-nuclear antibodies and anti-DNA tests were
negative, the complement levels were within normal
limits.

Table: Drugs inducing lupus erythematosus-like syndromes (15, 16).

DiphenyIhydantoin

p-Aminosalicylic acid

After cessation of vancomycin therapy, the patient’s
complaints persisted for the next two days and the
patient was put on steroid therapy. On the third day of
steroid therapy, eraptions were noted to fade beginning
from the trunk towards the distal parts of the body. All
clinical findings subsided completely within 10 days and
steroid therapy was eventually discontinued. On the 80th
day after his admission, the patient expired due to a large
newly formed vegetation.

Ethosuximide

Penicillin

Gold salt

Penicillamine

Serious cutaneous reactions to vancomycin are
uncommon (7). The occurrence of an erythematous,
flushing-type reaction termed “red man syndrome “ has
been reported following intravenous administration of
vancomycin (in 3-11 % of patients) whic is characterized
by flushing and itching, especially of the upper torso. In
severse cases, hypotension may occur (4-6, 10). This
phenomenon is believed to occur due to the direct effect
of histamine relase from the mast cells by
nonimmunologic processes (11). Other adverse effects
include nephrotoxicity (5%), rash (2-5%), neutropenia
(2%), otoxicity (1-5%), Stevens-Johnson Syndrome,
toxic epidermal necrolysis, fever of unknown origin and
rigors (5-8, 12, 13). There is only one case of a lupus
erythematosislike (LE) reaction due to vancomycin
described in the literature (in a patient with serious
staphylococcal infection ) (9). A large number of drugs
are reported to induce LE-like reactions (Table). Also
various drugs have been implicated in precipitating or
activating systemic lupus erythematosus (SLE) in 3-12 %
of cases (14). Drug-induced SLE. However, cutaneous and
renal manifestations are much rarer in drug-induced than
spontaneous SLE. The clinical and laboratory
manifestations usually, but not always subside when the
medication is discontinued (15). However, there are
features to suggest that drug-induced SLE differs from
the spontaneous disease: it is uncommon in black, it
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Acebutolol

Oral contraceptives, including

Allopurinol

Chlormadinone

Aminoglutethimide

Ethynyloestradiol

Aminosalycylic acid

Ethynodiol diacetae

Atenolol

Medroxyprogestorone

Captopril

Mestranol

Carbamazepine

Norethindrone

Clofibrate

Norethynodrel

Clonidine

Oxprenolol

Co-trimoxazole

Oxyphenisatin

Griseofulvin

Phenothiazine

Guanoxan

Phenylbutazone

Hydrallazine

Phenytoin

Ibuprofen

Pindolol

Isonicotinic acid hydrazide

Primidone

Isoniazed

Procainamide

Isoquinazepon

Propyranolol
PropylIthiouracil

Labetolol

Quinidine

Lithium

Reserpine

Methyldopa

Streptomycin

Methylphenylethylhydantoin

Sulphasalazine

Methylthouracil

Sulphonamides

Methysergide

Tertalol

Minoxidil

Tetracycline

Nitrofuradantin

Trimethadione

Nomisfensine

Venocuran

occurs in an older age group, renal and central nervous
system involvement is infrequent, antihistone antibodies
are frequent, anti DNA antibodies are absent and serum
complement is normal (14). In our patient, these findings
were almost identical.
Cutaneous involvement in drug-induced SLE may be in
the form of vasculitis, bullous, erythema multiforme or
may resemble pyoderma gangrenosum (16). In our
patient, vasculitis was documented histopatologically and
clinically.
Among the theories that explain the occurrence of
drug-induced LE, the widely accepted hypothesis is the
formation of drug-nucleoprotein complex which is
immunogenic in nature (16). Lesions with duration less
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than 2 months may however, give negative results, with
autoantibodies being formed in 6 months approximately
(17). This explains the negative results for
immunoflorescence studies and autoantibodies in our
patients.

Figure 1

Skin biopsy (hematoxylin-eosin,
X400):
epidermal
keratosis,
hydropic degeneration in the basal
cells prominent mixed infiltrate
composed primarily of neutrophils
and Iymphocytes around the
vessels

Figure 2.

Skin biopsy (hematoxylin-eosin,
X400):
epidermal
keratosis,
hydropic degeneration in the basal
cells prominent mixed infiltrate
composed primarily of neutrophils
and Iymphocytes around the
vessels

In conclusion, vancomycin, a potent antibiotic used in
severe infections, has serious side effects. Lupuslike
reaction is one of these side effects which should be
included in the list of side effects of this antimicrobial
agent.
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